OncoCyte Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
11 Apr 24 | Buy€93,369 | Andrew Arno | Individual | 33,898 | €2.75 | |
11 Apr 24 | Buy€9,337 | Joshua Riggs | Individual | 3,390 | €2.75 | |
11 Apr 24 | Buy€6,589,763 | Broadwood Capital, Inc. | Company | 2,420,000 | €2.72 |
Insider Trading Volume
Insider Buying: 7OC0 insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 5,647 | 0.0423% |
Individual Insiders | 469,667 | 3.51% |
Institutions | 1,184,556 | 8.86% |
Public Companies | 1,200,109 | 8.98% |
General Public | 4,821,306 | 36.1% |
Hedge Funds | 5,683,352 | 42.5% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 62.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
4,929,066 | €13.5m | 96.5% | 1.1% | |||
1,200,109 | €3.3m | 0% | no data | |||
754,286 | €2.1m | 0% | 0.29% | |||
523,928 | €1.4m | -3.92% | 1.32% | |||
330,018 | €906.0k | 0% | no data | |||
247,873 | €680.5k | 0% | no data | |||
123,211 | €338.2k | 0.19% | no data | |||
84,662 | €232.4k | 73.6% | no data | |||
69,072 | €189.6k | 0% | 100.0% | |||
62,433 | €171.4k | 1.55% | no data | |||
60,187 | €165.2k | 0% | no data | |||
55,885 | €153.4k | -22% | 0.06% | |||
29,161 | €80.1k | 0% | no data | |||
18,325 | €50.3k | 0% | no data | |||
16,289 | €44.7k | 0% | no data | |||
12,218 | €33.5k | -3.93% | no data | |||
10,000 | €27.5k | 0% | 0.05% | |||
3,767 | €10.3k | 0% | no data | |||
3,505 | €9.6k | 0% | no data | |||
2,509 | €6.9k | -16.6% | no data | |||
1,880 | €5.2k | -43.5% | no data | |||
1,016 | €2.8k | 0% | no data | |||
938 | €2.6k | 0% | 100.0% | |||
864 | €2.4k | -37.4% | no data | |||
500 | €1.4k | 0% | no data |